Cite

HARVARD Citation

    Wu, J. et al. (2019). Tyrosine kinase inhibitors for the treatment of rheumatoid arthritis: phase I to Ⅱ clinical trials. Expert opinion on investigational drugs. pp. 1113-1123. [Online]. 
  
Back to record